Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab Compared to Standard Trastuzumab-Based Chemotherapy Regimens for Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

PURPOSE: We evaluated the tolerability and cardiac safety of docetaxel, cyclophosphamide, and trastuzumab (TCyH) for the treatment of early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer and compared to the standard trastuzumab-based chemotherapy regimens doxorubicin wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jitawatanarat, Potjana, O'Connor, Tracey L., Kossoff, Ellen B., Levine, Ellis G., Chittawatanarat, Kaweesak, Ngamphaiboon, Nuttapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278055/
https://www.ncbi.nlm.nih.gov/pubmed/25548584
http://dx.doi.org/10.4048/jbc.2014.17.4.356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278055/
https://www.ncbi.nlm.nih.gov/pubmed/25548584
http://dx.doi.org/10.4048/jbc.2014.17.4.356

Ejemplares similares